Liver Diseases  >>  Stronger Neo-Minophagen C (ammoniated glycyrrhizin intravenous)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stronger Neo-Minophagen C (ammoniated glycyrrhizin intravenous) / Eisai, Minophagen
NCT00686881: Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)

Terminated
3
261
NA
Peginterferon alfa-2b (PegIFN-2b), SCH 054031, Pegylated interferon alfa-2b, Comparator: Stronger neo minophagen C (SNMC)
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
02/11
02/11

Download Options